semaglutide weight loss by month results week week: timeline from first dose to full results My thoughts after 12 months

It was first approved as Egrifta in November 2010 for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy, and it remains a prescription drug with a regulator-reviewed label, including a defined dose, defined contraindications, and required safety monitoring

doi: 10.1016/0026-0495(95)90288-0 277 GeneviveRMagousRMochizukiTLeNDMartinezJBaliJPet al

It will be as simple as Occidental

This effect may actually help protect the kidneys in patients with chronic kidney disease, as it is a result of efferent arteriolar vasodilation and a fall in intraglomerular pressure, which reduces renal hyperfiltration and protects the glomerular endothelium

It enhances insulin secretion, yes, but it also appears to improve fat tissue function, reduce inflammation in adipose tissue, and potentially improve how the body partitions nutrients between fat storage and energy use

Think salmon instead of crackers